Vocinti Indications/Uses

Gastric ulcer, duodenal ulcer, reflux esophagitis, prevention of recurrence of gastric ulcer or duodenal ulcer during low-dose aspirin administration, or prevention of recurrence of gastric ulcer or duodenal ulcer during NSAIDs administration.
Adjunct to Helicobacter pylori eradication in the followings: Gastric ulcer, duodenal ulcer, gastric MALT lymphoma, idiopathic thrombocytopenic purpura, the stomach after endoscopic resection of early stage gastric cancer, or Helicobacter pylori gastritis.
Precautions for Indications: Prevention of recurrence of gastric ulcer or duodenal ulcer during low-dose aspirin administration: This drug should be administered to the patients who are under continuous administration of low-dose aspirin for prevention of blood clots and emboli formation. History of gastric ulcer or duodenal ulcer should be confirmed before starting administration.
Prevention of recurrence of gastric ulcer or duodenal ulcer during NSAIDs administration: This drug should be administered to the patients who are under continuous administration of NSAIDs for purpose such as pain management of rheumatoid arthritis or osteoarthritis, etc. History of gastric ulcer or duodenal ulcer should be confirmed before starting administration.
Adjunct to Helicobacter pylori eradication: The efficacy of Helicobacter pylori eradication in the advanced stage of gastric MALT lymphoma has not been established.
Helicobacter pylori eradication should be conducted in the idiopathic thrombocytopenic purpura patients only if Helicobacter pylori eradication is considered appropriate with referring to the guidelines etc.
The efficacy on the prevention of gastric cancer by Helicobacter pylori eradication has not been established other than the stomach after endoscopic resection of early stage gastric cancer.
It should be confirmed that Helicobacter pylori is positive and Helicobacter pylori gastritis should be diagnosed by endoscopy before starting administration for patients with Helicobacter pylori gastritis.